Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord.
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Dexterity, visual perception, and activities of daily living in persons with multiple sclerosis.
Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the IMPROVER Diagnostic Signature Challenge.
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Teriflunomide for the treatment of relapsing multiple sclerosis: a review of clinical data.
Risk evaluation and monitoring in multiple sclerosis therapeutics.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy.
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
16 Syndrome in a Patient With Multiple Sclerosis.
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
The best clinical paper on multiple sclerosis in 2012: Commentary.
Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
Children and adolescents adjustment to parental multiple sclerosis: a systematic review.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Causes of upregulation of glycolysis in lymphocytes upon stimulation. A comparison with other cell types.
A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica.
Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin.
Pages
« first
‹ previous
…
468
469
470
471
472
473
474
475
476
…
next ›
last »